HRTS — Tema Heart & Health ETF

Is HRTS overbought or oversold? Here is the current MarketMoodz read.

ETF

Overbought As of November 17, 2026

Tema Heart & Health ETF (HRTS) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The ETF name last closed at $38.77. The rating moved from Neutral to Overbought on November 17, 2026.

See all overbought ETF stocks →

AI analysis

Primary drivers will be sector inflows, policy headlines around affordability and healthcare, and continued interest in active/specialized ETF wrappers; however, episodic retail-derivative volatility, potential regulatory changes to platform access, and limited public issuer disclosures elevate uncertainty. Near-term performance will be flow- and headline-sensitive, with upside if healthcare remains a favored tactical allocation and downside in periods of risk-off reallocations or liquidity stress.

Key factors

  • Healthcare-focused ETF exposure benefits from defensive demand amid tactical flows into healthcare-related sleeves
  • Policy tailwinds: Democratic affordability and healthcare-related legislative debate could channel headline-driven inflows into health-themed ETFs
  • Market tone driven by earnings momentum rather than macro shocks, supporting sector rotation into thematic and growth-adjacent ETFs
  • Active/alternatives inflows evidence suggests investor appetite for specialized ETF wrappers, which can support fund flows into niche health ETFs
  • Relative stability in rate expectations reduces headwinds from rising discount rates that can pressure equity ETF flows
  • Current lack of public financial filing detail increases emphasis on flows and sector drivers rather than issuer-level fundamentals

Risks

  • Retail derivative and leverage-driven episodic volatility (0DTE/options, autocallables) could create sharp intraday swings in ETF price and liquidity
  • Regulatory or platform changes from litigation (e.g., Robinhood disclosures) could restrict product access or change margining, reducing retail-driven inflows
  • Geopolitical headlines (Middle East intelligence reports) could trigger reallocation into traditional safe havens and away from risk-sensitive ETFs
  • Concentration or thematic risk: narrow-focus healthcare exposures may underperform broader indices if sector-specific headwinds appear
  • Limited issuer-disclosed financial data/EDGAR filings for the product increases uncertainty about expense, tracking, and liquidity characteristics
  • Market microstructure and liquidity risk for niche ETFs, especially during stressed market conditions, can widen spreads and magnify price moves

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for HRTS — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.